SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED
accepted and acknowledged
on 27 Mar 2023
Last Applicant/ Owned by
1200 Lenox Drive, Suite 100
Lawrenceville
NJ
08648
Serial Number
86383810 filed on 03rd Sep 2014
Registration Number
4989255 registered on 28th Jun 2016
Correspondent Address
Joan Optican Herman
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
UNISUN
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimiz Read More
Classification Information
Class [040]
Treatment & Processing of Materials Services
Manufacturing services for others in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, clinical manufacturing of drug formulations for others to support clinical trials, fabrication and preparation of active pharmaceutical ingredients for others, technology scale-up services for others, and integration of technology into manufacturing processes for others, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery
First Use Date in General
28th Aug 2014
First Use Date in Commerce
28th Aug 2014
Class [042]
Computer & Software Services & Scientific Services
Pharmaceutical drug delivery technology development services; pharmaceutical drug delivery technology development services, namely, research and development in the area of pharmaceutical drug delivery systems, including continuous release, pulsatile release, extended release, sustained release, and delayed release systems, consisting of selection of drug formulation and delivery systems to optimize performance of active pharmaceutical ingredients, analytic techniques to test drug formulations, analytic services to detect, identify and quantify drug components, stability testing, physical characterization of drug formulations, in-vitro release testing, all relating to multiple drug product formats, namely, semi-solids, solutions, suspensions, particulates, solid dispersions, solid solutions and injectables, all for inner ear delivery
First Use Date in General
28th Aug 2014
First Use Date in Commerce
28th Aug 2014
Mark Details
Serial Number
No 86383810
Mark Type
No Service Mark
Attorney Docket Number
No 46607-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Mar 2023 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| 15th Feb 2023 | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED |
| 04th Oct 2022 | POST REGISTRATION ACTION MAILED - SEC. 8 & 15 |
| 04th Oct 2022 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| 06th Apr 2022 | TEAS SECTION 8 & 15 RECEIVED |
| 28th Jun 2021 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| 14th Oct 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 07th Oct 2020 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
| 28th Jun 2016 | REGISTERED-PRINCIPAL REGISTER |
| 24th May 2016 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |